Twenty-seven years of phase III trials for patients with extensive disease small-cell lung cancer: disappointing results.

PloS One
Isao OzeMitsune Tanimoto

Abstract

Few studies have formally assessed whether treatment outcomes have improved substantially over the years for patients with extensive disease small-cell lung cancer (ED-SCLC) enrolled in phase III trials. The objective of the current investigation was to determine the time trends in outcomes for the patients in those trials. We searched for trials that were reported between January 1981 and August 2008. Phase III randomized controlled trials were eligible if they compared first-line, systemic chemotherapy for ED-SCLC. Data were evaluated by using a linear regression analysis. In total, 52 trials were identified that had been initiated between 1980 and 2006; these studies involved 10,262 patients with 110 chemotherapy arms. The number of randomized patients and the proportion of patients with good performance status (PS) increased over time. Cisplatin-based regimens, especially cisplatin and etoposide (PE) regimen, have increasingly been studied, whereas cyclophosphamide, doxorubicin, and vincristine-based regimens have been less investigated. Multiple regression analysis showed no significant improvement in survival over the years. Additionally, the use of a PE regimen did not affect survival, whereas the proportion of patients ...Continue Reading

References

Jul 1, 1989·Chest·J F Smyth
Jun 1, 1995·Chest·W J O'Donnell
Mar 18, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J von PawelR Gralla
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J P ChuteB E Johnson
Jan 11, 2002·The New England Journal of Medicine·Kazumasa NodaUNKNOWN Japan Clinical Oncology Group
Dec 19, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stein SundstrømUNKNOWN Norwegian Lung Cancer Study Group
Jan 15, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kaoru KubotaUNKNOWN Japanese Taxotere Lung Cancer Study Group
Oct 12, 2004·Biostatistics·Ori Davidov, Marvin Zelen
May 2, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nasser HannaAlan Sandler
Aug 19, 2007·The New England Journal of Medicine·Ben SlotmanUNKNOWN EORTC Radiation Oncology Group and Lung Cancer Group
Oct 5, 2007·The Oncologist·Brian E LallyMichael C Perry
Dec 20, 2007·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Frances A ShepherdUNKNOWN International Association for the Study of Lung Cancer International Staging Committee and Participating Institutions
Oct 16, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Akira InoueToshihiro Nukiwa
Apr 8, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Primo N LaraDavid R Gandara

❮ Previous
Next ❯

Citations

Mar 22, 2014·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·M FieglW Hilbe
Feb 1, 2013·Molecular Cancer Therapeutics·Chandrashekhar D KamatChristine L Hann
Jul 4, 2013·Oncology Reports·Beverly A Teicher
Jan 1, 2011·Multidisciplinary Respiratory Medicine·Bojan ZaricMilan Antonic
Feb 18, 2010·Investigational New Drugs·Ulrike OlszewskiGerhard Hamilton
Aug 29, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M Reck
Jun 22, 2011·Nature Reviews. Clinical Oncology·William N William, Bonnie S Glisson
Apr 17, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Anish ThomasGiuseppe Giaccone
May 28, 2013·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Osamu TakakuwaAkio Niimi
Jan 20, 2016·The ISME Journal·Steven R Parratt, Anna-Liisa Laine
Feb 9, 2013·Seminars in Oncology·James Smith, Diane Reidy-Lagunes
May 14, 2011·Lancet·Jan P van MeerbeeckDirk K M De Ruysscher
Feb 22, 2011·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Naoyuki NogamiMitsune Tanimoto
Feb 14, 2013·Genes, Chromosomes & Cancer·Elīna ZandbergaAija Linē
Oct 23, 2014·Cancer·Lauren Averett Byers, Charles M Rudin
Jul 1, 2011·Critical Reviews in Oncology/hematology·Antoinette Wozniak
Jun 7, 2013·Journal of the National Cancer Institute·J T PoirierCharles M Rudin
Jul 28, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Martin ReckDavid Spigel
Jun 27, 2017·The Journal of Clinical Investigation·Linde A MilesCharles M Rudin
May 4, 2018·American Journal of Therapeutics·Maryann R CooperCheryl R Durand
Jun 13, 2018·Journal of Oncology Practice·Jun Gong, Ravi Salgia
Sep 25, 2019·Cancers·Max Hardy-WerbinEdurne Arriola
Nov 28, 2013·The Cochrane Database of Systematic Reviews·Marta Pelayo AlvarezXavier Bonfill Cosp
Jun 25, 2019·British Journal of Cancer·Daniel MorgenszternSukhmani K Padda
Sep 27, 2018·Japanese Journal of Clinical Oncology·Nobuaki OchiNagio Takigawa
Oct 26, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jih-Hsiang LeeGiuseppe Giaccone
May 11, 2017·Cancer Research·Sai Kiran SharmaJason S Lewis

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.